Dominik Dytfeld

5PUBLICATIONS
36CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2026
Diving into the transcriptional landscape of leukemic stem cells in acute myeloid leukemia at single-cell resolution.

|Oct 16, 2025
Carfilzomib resistance in multiple myeloma: A comparative metabolomic analysis.

Krzysztof Żyłka, Magdalena Łuczak, Magdalena Kostrzewska-Poczekaj

|Jul 07, 2025
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.

Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro

|Sep 10, 2023
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.

Tadeusz Kubicki, Dominik Dytfeld, Tomasz Wróbel

|Aug 12, 2022
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial.

Meletios A Dimopoulos, Dominik Dytfeld, Sebastian Grosicki

Pageof 1

Frequent Collaborators

2 joint publications

Meletios A Dimopoulos

2 joint publications

Jesús San-Miguel

2 joint publications

Lidia Gil

1 joint publications

Philippe Moreau